BUDESONIDE BIOGARAN 3 mg, modified-release capsule 45 capsules
Active ingredients: Budesonide
Commercialized according to BDPMDispensing in France: Prescription only
Modified-release capsule45 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BUDESONIDE BIOGARAN 3 mg, gélule à libération modifiée
- Pharmaceutical form
- gélule à libération modifiée
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 45 gélule(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 9 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69795280CIP73025553CIP133400930255537Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BUDÉSONIDEgélule | 3 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.